Christopher M. Booth
Christopher M. Booth publishes mostly in Oncology, Economics and Econometrics and Surgery, on topics such as Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Bladder and Urothelial Cancer Treatments.
- World rank
- #115,503 of 7,710,434 ranked researchers
- Rank in Canada
- #3,710 of 183,316
- Works
- 458
- Citations
- 14k
- Citations per work
- 31.6
What does Christopher M. Booth research?
Christopher M. Booth's work is mostly in Medicine (52%), Economics, Econometrics and Finance (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23751.7%
- Medicine23751.7%
- Everything else15032.7%
- Social Sciences7115.6%
- 1Oncology22% of their works
- 2Economics and Econometrics16% of their works
- 3Surgery12% of their works
- 4Pulmonary and Respiratory Medicine9% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Epidemiology3% of their works
Research topics
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Bladder and Urothelial Cancer Treatments
- Colorectal Cancer Treatments and Studies
- Global Cancer Incidence and Screening
- Cancer survivorship and care
- Colorectal Cancer Surgical Treatments
- Urinary and Genital Oncology Studies
Which keywords describe Christopher M. Booth's research?
The keywords of their largest research topics: Cost of Care, Financial Toxicity, Quality of Life, Chemotherapy, Neoadjuvant Therapy, Cost-effectiveness Analysis, Health Utility Measures and Bladder Cancer.
- Rectal Cancer
- Preoperative Chemoradiotherapy
- Cancer Survivorship
- Cancer Incidence
- Cetuximab
- Bladder Cancer
- Cost-effectiveness Analysis
- Chemotherapy
- Financial Toxicity
- Cost of Care
- Quality of Life
- Neoadjuvant Therapy
- Health Utility Measures
- Urothelial Carcinoma
- KRAS Mutations
- Mortality Rates
- Patient-Reported Outcomes
- Primary Urethral Carcinoma
- Urachal Carcinoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cost of Care1101 topic
- Financial Toxicity1101 topic
- Quality of Life1102 topics
- Chemotherapy1022 topics
- Neoadjuvant Therapy922 topics
- Cost-effectiveness Analysis721 topic
- Health Utility Measures721 topic
- Bladder Cancer571 topic
- Urothelial Carcinoma571 topic
- Cetuximab451 topic
- KRAS Mutations451 topic
- Cancer Incidence401 topic
- Mortality Rates401 topic
- Cancer Survivorship381 topic
- Patient-Reported Outcomes381 topic
- Preoperative Chemoradiotherapy351 topic
- Primary Urethral Carcinoma351 topic
- Rectal Cancer351 topic
- Urachal Carcinoma351 topic
Where does Christopher M. Booth work?
Christopher M. Booth's main affiliation in the publication record is Queen's University, Canada.
How many publications and citations does Christopher M. Booth have?
OpenAlex counts 458 works and 14,459 citations for Christopher M. Booth, an h-index of 57, ranking #115,503 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Christopher M. Booth
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christopher M. Booth. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.